Article

jdsupra.com on 2020-04-07 22:42

Rituximab Biosimilar Updates from Europe

We previously reported that applications for initial marketing authorization for two rituximab biosimilars were withdrawn from the European Medicines ...

Related news

Biosimilar Updates: Epoetin, Rituximab, Adalimumab jdsupra.com
FDA Approves First Rituximab Biosimilar jdsupra.com
California , United States , Switzerland
Rituximab IPR Updates jdsupra.com
California , United States , Switzerland
Biosimilar Regulatory Submission Updates: Europe, U.S., Japan, Canada jdsupra.com
California , United States , Switzerland , Canada , Japan
IPR Updates: Trastuzumab, Rituximab, Abatacept jdsupra.com
California , United States , Switzerland
Rituximab and Adalimumab IPR Updates jdsupra.com
California , United States , Switzerland
Biosimilar Pipeline Developments: Rituximab, Adalimumab, Eculizumab, Infliximab, Pegfilgrastim jdsupra.com
California , United States , Switzerland
Teva and Celltrion Launch Rituximab Biosimilar in US jdsupra.com
California , United States , Switzerland
Biosimilar Clinical Trial Updates jdsupra.com
California , United States , Switzerland
Global Biosimilar Development Updates jdsupra.com
California , United States , Switzerland
Biosimilar Market Updates jdsupra.com
California , United States , Switzerland
Biosimilar IPR Appeal Updates jdsupra.com
California , United States , Switzerland
PTAB Updates: Trastuzumab, Rituximab, Filgrastim, Pegfilgrastim, Insulin Glargine jdsupra.com
California , United States , Switzerland
Biosimilar and Biologic Development Updates jdsupra.com
California , United States , Switzerland
JHL Biotech to Initiate Global Phase III Clinical Study of Rituximab Biosimilar Candidate jdsupra.com
California , United States , Switzerland
Biologic and Biosimilar Litigation Updates jdsupra.com
California , United States , Switzerland
Biosimilar-Related Patent Litigation Updates jdsupra.com
California , United States , Switzerland
Biosimilar Approval Updates in Europe and China jdsupra.com
Shanghai , Ireland , Netherlands , China , Europe
Mundipharma Launches Pegfilgrastim Biosimilar in Europe jdsupra.com
California , United States , Switzerland , Europe